Breaking News Instant updates and real-time market news.

2023-01-25 08:23:16 HBRM Herborium Group / + 08:23 01/25/23 01/25 08:23 01/25/23 08:23	Herborium Group shares a shareholders update letter part 2 Herborium Group shares a Shareholders Update Letter Part 2 from the CEO, Dr. Agnes Olszewski. "Following last week's Shareholder Letter Part 1, this Part 2 is to present the major focus for 2023 and beyond. This Plan stems from the analysis of lead market and scientific trends that are reshaping our space, and grounded in previously reported changes and advancements made in 2022. New Products... Herborium's acne treatment represents such a unique product. We are presently working on the second generation of this clinically validated skincare solution that has a better consumer characteristics and improved business profile. The Company is also approaching the most advance science in clinical skincare- stem cell based products. We are working to add two highly innovative products in this category, to our 2023 product portfolio. New Partners... We are presently in advanced talks with two companies - one from the US and a second from South Korea that is well known in cosmetic and skin wellness industry for high quality biotechnological applications in skincare. New Platform. As reported in Part 1 of Shareholders Letter, Herborium already commenced the transformation process from A Product Company to A Content & Product Player in the Sector of Natural Skincare and Wellness... We expect to progress aggressively with completing and launching this AI driven platform in 2023."

2023-01-25 08:23:16

HBRM

Herborium Group

/ +

08:23

01/25/23

01/25

08:23

01/25/23

08:23

Herborium Group shares a shareholders update letter part 2

Herborium Group shares a Shareholders Update Letter Part 2 from the CEO, Dr. Agnes Olszewski. "Following last week's Shareholder Letter Part 1, this Part 2 is to present the major focus for 2023 and beyond. This Plan stems from the analysis of lead market and scientific trends that are reshaping our space, and grounded in previously reported changes and advancements made in 2022. New Products... Herborium's acne treatment represents such a unique product. We are presently working on the second generation of this clinically validated skincare solution that has a better consumer characteristics and improved business profile. The Company is also approaching the most advance science in clinical skincare- stem cell based products. We are working to add two highly innovative products in this category, to our 2023 product portfolio. New Partners... We are presently in advanced talks with two companies - one from the US and a second from South Korea that is well known in cosmetic and skin wellness industry for high quality biotechnological applications in skincare. New Platform. As reported in Part 1 of Shareholders Letter, Herborium already commenced the transformation process from A Product Company to A Content & Product Player in the Sector of Natural Skincare and Wellness... We expect to progress aggressively with completing and launching this AI driven platform in 2023."

OTHER BREAKING NEWS FROM THE FLY

Downgrade	Kesko downgraded to Hold from Buy at Danske Bank » 05:12 02/03/23 02/03 05:12 02/03/23 05:12 KKOYY Kesko $11.47 / -0.64 (-5.28%) Danske Bank analyst Calle… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KKOYY Kesko $11.47 / -0.64 (-5.28%) 01/24/23 DNB Markets Kesko initiated with a Buy at DNB Markets
Upgrade	EMS-Chemie upgraded to Buy from Hold at Kepler Cheuvreux » 05:11 02/03/23 02/03 05:11 02/03/23 05:11 EMSHF EMS-Chemie $670.30 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research EMSHF EMS-Chemie $670.30 / + (+0.00%) 12/13/22 Berenberg EMS-Chemie price target raised to CHF 600 from CHF 590 at Berenberg 12/13/22 Stifel EMS-Chemie downgraded to Hold from Buy at Stifel 10/31/22 Berenberg EMS-Chemie downgraded to Hold from Buy at Berenberg 10/18/22 Baader Helvea EMS-Chemie downgraded to Reduce from Add at Baader Helvea
Downgrade	Insurance Australia downgraded to Neutral from Overweight at JPMorgan » 05:11 02/03/23 02/03 05:11 02/03/23 05:11 IAUGY Insurance Australia $17.31 / +0.13 (+0.76%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research IAUGY Insurance Australia $17.31 / +0.13 (+0.76%) 01/24/23 Goldman Sachs Insurance Australia initiated with a Neutral at Goldman Sachs 01/11/23 JPMorgan Insurance Australia upgraded to Overweight from Neutral at JPMorgan
Upgrade	Cardinal Health upgraded to Outperform from Neutral at Baird » 05:09 02/03/23 02/03 05:09 02/03/23 05:09 CAH Cardinal Health $76.33 / +0.62 (+0.82%) Baird analyst Eric… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CAH Cardinal Health $76.33 / +0.62 (+0.82%) 12/19/22 Cardinal Health announces Aaron Alt as chief financial officer 12/12/22 Yellow Corp appoints Annlea Rumfola as CIO 11/14/22 Elliott made Triple Flag Precious Metals top holding during Q3 09/15/22 PayrHealth announces collaboration with Cardinal Health CAH Cardinal Health $76.33 / +0.62 (+0.82%) 01/31/23 UBS Cardinal Health price target raised to $91 from $78 at UBS 11/22/22 Credit Suisse Cardinal Health price target raised to $79 from $64 at Credit Suisse 11/14/22 Mizuho Cardinal Health price target raised to $74 from $66 at Mizuho 11/07/22 Baird Cardinal Health price target raised to $82 from $74 at Baird CAH Cardinal Health $76.33 / +0.62 (+0.82%) 02/02/23 Cardinal Health raises FY23 EPS view to $5.20-$5.50 from $5.05-$5.40 02/02/23 Cardinal Health reports Q2 EPS $1.32, consensus $1.14 02/01/23 Notable companies reporting before tomorrow's open 02/01/23 Notable companies reporting before tomorrow's open CAH Cardinal Health $76.33 / +0.62 (+0.82%) 09/22/22 Activist Elliott would like to see Pinterest put up for sale, Barron's says 08/15/22 Elliott has large stake in Cardinal Health, seeks board seats, WSJ says CAH Cardinal Health $76.33 / +0.62 (+0.82%) 11/04/22 Fly Intel: Pre-market Movers 09/28/22 #SocialStocks: Details of Musk's deposition by Twitter still being hammered out 08/15/22 What You Missed On Wall Street On Monday 08/11/22 Fly Intel: Pre-market Movers CAH Cardinal Health $76.33 / +0.62 (+0.82%) 12/02/22 Early notable gainers among liquid option names on December 2nd 11/11/22 Cardinal Health put volume heavy and directionally bearish 10/10/22 Cardinal Health call volume above normal and directionally bullish 08/12/22 Early notable gainers among liquid option names on August 12th
Downgrade	Spirit AeroSystems downgraded to Sector Perform from Outperform at RBC Capital » 05:08 02/03/23 02/03 05:08 02/03/23 05:08 SPR Spirit AeroSystems $36.06 / -0.08 (-0.22%) RBC Capital analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SPR Spirit AeroSystems $36.06 / -0.08 (-0.22%) 11/07/22 Spirit AeroSystems rises 13.1% 10/19/22 Spirit AeroSystems enters MOU with Joramco for MRO services cooperation 09/21/22 Spirit AeroSystems enters MOU with MAB to develop MRO services for 737 aircraft 09/20/22 Spirit AeroSystems SEAS joint venture to open in October SPR Spirit AeroSystems $36.06 / -0.08 (-0.22%) 01/09/23 Truist Spirit AeroSystems price target raised to $42 from $39 at Truist 11/11/22 BofA BofA double downgrades '737 story' Spirit AeroSystems to Underperform 11/11/22 BofA Spirit AeroSystems downgraded to Underperform from Buy at BofA 11/07/22 Wolfe Research Spirit AeroSystems upgraded to Peer Perform from Underperform at Wolfe Research SPR Spirit AeroSystems $36.06 / -0.08 (-0.22%) 11/03/22 Spirit AeroSystems reports Q3 EPS (15c), consensus (40c) 11/02/22 Notable companies reporting before tomorrow's open 11/02/22 Notable companies reporting before tomorrow's open 08/03/22 Spirit AeroSystems reports Q2 adjusted EPS ($1.21), consensus (24c) SPR Spirit AeroSystems $36.06 / -0.08 (-0.22%) 11/11/22 What You Missed On Wall Street On Friday 11/11/22 What You Missed On Wall Street This Morning 11/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/08/22 What You Missed On Wall Street On Thursday 02/15/23 44th Annual Aerospace/Defense & Industrials Conference 02/07/23 Spirit AeroSystems - SPR SPR Spirit AeroSystems $36.06 / -0.08 (-0.22%) 12/29/22 Largest borrow rate increases among liquid names
Downgrade	Boeing downgraded to Sector Perform from Outperform at RBC Capital » 05:08 02/03/23 02/03 05:08 02/03/23 05:08 BA Boeing $209.24 / -5.265 (-2.45%) RBC Capital analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BA Boeing $209.24 / -5.265 (-2.45%) 02/01/23 Boeing awarded $1.62B Air Force contract 02/01/23 Atlas Air takes delivery of final 747 to be produced by Boeing 01/31/23 Atlas Air takes delivery of Boeing's final 747 production aircraft 01/30/23 Boeing awarded U.S. Air Force contract for 15 KC-46A tankers BA Boeing $209.24 / -5.265 (-2.45%) 01/30/23 Jefferies Boeing price target raised to $250 from $240 at Jefferies 01/26/23 Morgan Stanley Boeing remains a 'show me story,' says Morgan Stanley 01/12/23 Credit Suisse Credit Suisse upgrades Boeing to Neutral, raises price target to $200 01/12/23 Credit Suisse Boeing upgraded to Neutral from Underperform at Credit Suisse BA Boeing $209.24 / -5.265 (-2.45%) 01/25/23 Boeing reports Q4 core EPS ($1.75), consensus 26c 01/24/23 Notable companies reporting before tomorrow's open 01/24/23 Notable companies reporting before tomorrow's open 10/26/22 Boeing reports Q3 core EPS ($6.18), consensus 2c BA Boeing $209.24 / -5.265 (-2.45%) 01/30/23 Boeing to open 737 Max line at Everett plant, The Air Current says 01/27/23 Boeing expects to hire 10,000 staff in 2023, Reuters reports 01/26/23 Boeing pleads not guilty in 737 MAX fraud case, Bloomberg says 01/11/23 Boeing 737 MAX flights scheduled by China Southern for Friday, Reuters reports BA Boeing $209.24 / -5.265 (-2.45%) 01/26/23 What You Missed On Wall Street This Morning 01/25/23 What You Missed On Wall Street On Wednesday 01/25/23 What You Missed On Wall Street This Morning 01/25/23 Fly Intel: Pre-market Movers BA Boeing $209.24 / -5.265 (-2.45%) 01/25/23 Unusually active option classes on open January 25th 01/06/23 Unusually active option classes on open January 6th 12/12/22 Boeing call volume above normal and directionally bullish 12/09/22 Unusually active option classes on open December 9th
Downgrade	Travel + Leisure downgraded to Hold from Buy at Jefferies » 05:06 02/03/23 02/03 05:06 02/03/23 05:06 TNL Travel + Leisure $44.20 / +1.345 (+3.14%) Jefferies analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events TNL Travel + Leisure $44.20 / +1.345 (+3.14%) 11/15/22 Truist Travel + Leisure price target lowered to $60 from $72 at Truist 10/28/22 Deutsche Bank Travel + Leisure price target lowered to $62 from $69 at Deutsche Bank 10/28/22 Credit Suisse Travel + Leisure downgraded to Underperform from Outperform at Credit Suisse 08/12/22 Truist Travel + Leisure price target lowered to $72 from $78 at Truist TNL Travel + Leisure $44.20 / +1.345 (+3.14%) 10/27/22 Travel + Leisure sees FY22 adjusted EBITDA $855M-$865M 10/27/22 Travel + Leisure reports Q3 adjusted EPS $1.28, consensus $1.30 09/15/22 Travel + Leisure backs Q3 adjusted EBITDA view $230M-$240M TNL Travel + Leisure $44.20 / +1.345 (+3.14%) 12/14/22 Fly Intel: After-Hours Movers 10/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 09/16/22 What You Missed On Wall Street On Friday 09/16/22 What You Missed On Wall Street This Morning 02/22/23 Travel + Leisure - TNL
Downgrade	Hilton Grand Vacations downgraded to Hold from Buy at Jefferies » 05:05 02/03/23 02/03 05:05 02/03/23 05:05 HGV Hilton Grand Vacations $49.58 / +1.65 (+3.44%) Jefferies analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly HGV Hilton Grand Vacations $49.58 / +1.65 (+3.44%) 11/09/22 Hilton Grand Vacations sees FY22 adjusted EBITDA $1.03B-$1.05B HGV Hilton Grand Vacations $49.58 / +1.65 (+3.44%) 12/15/22 Barclays Hilton Grand Vacations price target raised to $50 from $49 at Barclays 11/15/22 Truist Hilton Grand Vacations price target lowered to $62 from $63 at Truist 08/12/22 Truist Hilton Grand Vacations price target lowered to $63 from $64 at Truist 06/28/22 Barclays Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names HGV Hilton Grand Vacations $49.58 / +1.65 (+3.44%) 11/09/22 Hilton Grand Vacations reports Q3 EPS $1.24, consensus 77c 08/09/22 Hilton Grand Vacations backs FY22 adjusted EBITDA view $960M-$990M 08/09/22 Hilton Grand Vacations reports Q2 EPS with-items 60c, consensus 88c HGV Hilton Grand Vacations $49.58 / +1.65 (+3.44%) 11/09/22 Fly Intel: Pre-market Movers
Hot Stocks	Volvo CFO Tina Hultkvist to resign » 05:02 02/03/23 02/03 05:02 02/03/23 05:02 VLVLY Volvo $20.55 / +0.36 (+1.78%) Tina Hultkvist has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VLVLY Volvo $20.55 / +0.36 (+1.78%) 12/07/22 Volvo receives order for 36 electric trucks from Team Global Express 10/25/22 Volvo spins out new start-up company Fyrqom AB 10/06/22 Volvo Trucks to deliver 20 fully electric heavy-duty trucks to Amazon 10/04/22 Volvo, Universal Technical Institute expand manufacturer-paid training program VLVLY Volvo $20.55 / +0.36 (+1.78%) 01/18/23 JPMorgan Volvo price target raised to SEK 190 from SEK 175 at JPMorgan 10/24/22 JPMorgan Volvo price target lowered to SEK 175 from SEK 205 at JPMorgan 10/21/22 RBC Capital Volvo price target lowered to SEK 201 from SEK 229 at RBC Capital 10/21/22 Citi Volvo price target lowered to SEK 202 from SEK 210 at Citi VLVLY Volvo $20.55 / +0.36 (+1.78%) 01/26/23 Volvo reports Q4 EPS SEK 3.26 vs. SEK 3.93 10/20/22 Volvo reports Q3 EPS SEK 4.24 vs. SEK 3.47 last year
Hot Stocks	Qudian regains compliance with NYSE » 05:00 02/03/23 02/03 05:00 02/03/23 05:00 QD Qudian $1.23 / +0.035 (+2.93%) Qudian announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Options QD Qudian $1.23 / +0.035 (+2.93%) 09/23/22 Qudian receives noncompliance notice from NYSE QD Qudian $1.23 / +0.035 (+2.93%) 10/07/22 Largest borrow rate increases among liquid names

Downgrade	Vodafone downgraded to Sell from Buy at DZ Bank » 04:56 02/03/23 02/03 04:56 02/03/23 04:56 VOD Vodafone $11.62 / +0.21 (+1.84%) DZ Bank analyst Matthias… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options VOD Vodafone $11.62 / +0.21 (+1.84%) 02/02/23 Vodafone Ireland selects Amdocs for cloud project 12/05/22 Vodafone Group CEO Nick Read to step down 11/09/22 IBM, Vodafone announce cybersecurity partnership 11/09/22 KKR consortium enters co-control pact for Vodafone 81.7% stake in Vantage Towers VOD Vodafone $11.62 / +0.21 (+1.84%) 02/02/23 Barclays Vodafone price target lowered to 115 GBp from 120 GBp at Barclays 02/02/23 JPMorgan Vodafone price target lowered to 95 GBp from 97 GBp at JPMorgan 01/23/23 Deutsche Bank Vodafone price target lowered to 195 GBp from 215 GBp at Deutsche Bank 01/12/23 BofA Vodafone upgraded to Buy from Neutral at BofA VOD Vodafone $11.62 / +0.21 (+1.84%) 10/25/22 Liberty, Telefonica exploring sale of Cornerstone stake, Bloomberg reports 10/10/22 DigitalBridge, Brookfield mull bidding on Vantage stake, Bloomberg says 10/10/22 DigitalBridge, Brookfield weigh bidding on Vantage stake, Bloomberg says 10/07/22 American Tower weighing offer for stake in Vodafone's Vantage, Bloomberg reports VOD Vodafone $11.62 / +0.21 (+1.84%) 11/09/22 What You Missed On Wall Street On Wednesday 11/09/22 What You Missed On Wall Street This Morning 10/10/22 What You Missed On Wall Street On Monday 10/07/22 What You Missed On Wall Street On Friday VOD Vodafone $11.62 / +0.21 (+1.84%) 01/17/23 Unusually active option classes on open January 17th 01/12/23 Vodafone call volume above normal and directionally bullish 01/11/23 Unusual call flow in option market yesterday 12/16/22 Vodafone call volume above normal and directionally bullish
Downgrade	Telia downgraded to Underperform from Market Perform at Bernstein » 04:56 02/03/23 02/03 04:56 02/03/23 04:56 TLSNY Telia $5.30 / +0.095 (+1.83%) Bernstein analyst Stan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TLSNY Telia $5.30 / +0.095 (+1.83%) 02/01/23 Morgan Stanley Telia price target lowered to SEK 28 from SEK 29 at Morgan Stanley 01/13/23 Morgan Stanley Telia price target lowered to SEK 29 from SEK 30 at Morgan Stanley 01/11/23 UBS Telia downgraded to Neutral from Buy at UBS 01/11/23 Exane BNP Paribas Telia downgraded to Underperform from Neutral at Exane BNP Paribas
Conference/Events	Oppenheimer healthcare analysts hold an analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 Healthcare Analysts,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	Cantor Fitzgerald biotech analysts to hold analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 DNLI Denali Therapeutics $32.66 / +1.86 (+6.04%) Biotechnology Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events DNLI Denali Therapeutics $32.66 / +1.86 (+6.04%) 01/25/23 Denali Therapeutics announces achievement of RIPK1 milestone for Phase 2 trial 01/09/23 Centogene, Denali extend observational study on Parkinson's disease genetics 01/09/23 Denali Therapeutics announces 2023 milestones 12/05/22 Denali Therapeutics announces DNL343 interim Phase 1b data in ALS DNLI Denali Therapeutics $32.66 / +1.86 (+6.04%) 01/30/23 SVB Securities Denali Therapeutics initiated with an Outperform at SVB Securities 12/06/22 Cantor Fitzgerald Denali interim P1b study results in ALS 'positive,' says Cantor Fitzgerald 12/05/22 Cowen Denali Therapeutics initiated with an Outperform at Cowen 11/02/22 BTIG Denali Therapeutics upgraded to Buy from Neutral at BTIG DNLI Denali Therapeutics $32.66 / +1.86 (+6.04%) 11/03/22 Denali Therapeutics reports Q3 EPS (84c), consensus (81c) 08/08/22 Denali Therapeutics reports Q2 EPS (48c), consensus (55c) 20 Oct DNLI Denali Therapeutics $32.66 / +1.86 (+6.04%) 11/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/03/22 Fly Insider: Clear Channel, Nikola among weeks notable insider trades 10/03/22 Biotech Alert: Searches spiking for these stocks today 12:00 Today Biotechnology 02/06/23 Biotech Ski Summit
Conference/Events	JMP Securities pharmaceuticals analyst to hold analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 Pharmaceuticals Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	DA Davidson consumer analysts to hold analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 Consumer Analysts, along… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	JPMorgan networking equipment analyst to hold analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 GLW Corning $36.31 / +1.025 (+2.90%) , JNPR Juniper $31.45 / +0.445 (+1.44%) , QCOM Qualcomm $135.65 / -2.84 (-2.05%) Networking Equipment/IT… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GLW JNPR QCOM GLW Corning $36.31 / +1.025 (+2.90%) 01/26/23 Corning Gorilla Glass Victus 2 used in Samsung Galaxy smartphones 01/18/23 PGT Innovations to partner with Corning on advanced window technologies 11/30/22 Corning unveils Corning Gorilla Glass Victus 2 09/15/22 Corning receives $103.8M in additional funding from BARDA JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Juniper CFO says aiming to expand 2023 operating margin by at least 100bps 12/12/22 Juniper selected as preferred technology partner for Deutsche Telekom's SD-X 12/07/22 Juniper CEO sells $604K in common stock 10/28/22 Juniper director Kriens sells 140,000 common shares QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Qualcomm expects weak handset market to persist through 1H23 02/02/23 Qualcomm sees Q2 QCT revenue $7.4B-$8B 02/02/23 Qualcomm CEO says long-term trends driving demand 'intact' 01/31/23 Mobile phone, PC shipments to fall another 4.4% in 2023, Gartner says GLW JNPR QCOM GLW Corning $36.31 / +1.025 (+2.90%) 02/02/23 Susquehanna Corning price target raised to $40 from $39 at Susquehanna 01/04/23 Credit Suisse Corning upgraded to Outperform from Neutral at Credit Suisse 12/20/22 JPMorgan Corning price target lowered to $40 from $44 at JPMorgan 12/13/22 Morgan Stanley Corning price target lowered to $35 from $36 at Morgan Stanley JNPR Juniper $31.45 / +0.445 (+1.44%) 02/01/23 Barclays Juniper price target raised to $40 from $34 at Barclays 02/01/23 Citi Juniper price target raised to $35 from $30 at Citi 01/17/23 Piper Sandler Juniper price target raised to $32 from $31 at Piper Sandler 12/20/22 JPMorgan JPMorgan ups Juniper target, adds to Analyst Focus List QCOM Qualcomm $135.65 / -2.84 (-2.05%) 01/23/23 Barclays Qualcomm upgraded to Overweight from Equal Weight at Barclays 01/18/23 Citi Citi opens 'negative catalyst watch' on Intel and Qualcomm 01/11/23 KeyBanc KeyBanc says iPhone survey shows supply partial recovery, some shortages remain 01/10/23 Piper Sandler Piper Sandler sees no strategic reason for Apple to insource Wi-Fi combo chip GLW JNPR QCOM GLW Corning $36.31 / +1.025 (+2.90%) 01/31/23 Corning sees Q1 core EPS 35c-42c, consensus 47c 01/31/23 Corning reports Q4 adjusted EPS 47c, consensus 44c 01/30/23 Notable companies reporting before tomorrow's open 01/30/23 Notable companies reporting before tomorrow's open JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Juniper raises quarterly dividend to 22c from 21c per share 01/31/23 Juniper sees Q1 EPS 37c-47c, consensus 40c 01/31/23 Juniper reports preliminary Q4 EPS 65c, consensus 65c 01/31/23 Notable companies reporting after market close QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Qualcomm sees Q2 adjusted EPS $2.05-$2.25, consensus $2.26 02/02/23 Qualcomm reports Q1 adjusted EPS $2.37, consensus $2.34 02/02/23 Notable companies reporting after market close 11/02/22 Qualcomm sees Q1 adjusted EPS adjusted EPS $2.25-$2.45, consensus $3.42 JNPR QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 08/27/22 Juniper Networks' AI strategy could push stock higher, Barron's says QCOM Qualcomm $135.65 / -2.84 (-2.05%) 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/11/23 TSMC receives 3nm chip orders from Broadcom, DigiTimes reports 01/09/23 Apple aims to replace Broadcom modem by 2025, Bloomberg says JNPR QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Fly Intel: After-Hours Movers 10/25/22 Fly Intel: After-Hours Movers 08/17/22 Here's what Wall Street experts are saying about Cisco ahead of earnings QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Fly Intel: After-Hours Movers 02/02/23 What Wall Street is saying about Apple ahead of earnings 02/02/23 Here's what Wall Street is saying about Qualcomm ahead of earnings 01/23/23 What You Missed On Wall Street On Monday 10:30 Today Networking Equipment/IT Hardware 13:30 Today Networking Equipment/IT Hardware 02/08/23 Networking Equipment/IT Hardware 02/15/23 Juniper 02/16/23 Juniper 03/08/23 Qualcomm Inc. GLW JNPR QCOM GLW Corning $36.31 / +1.025 (+2.90%) 08/29/22 Corning put volume heavy and directionally bearish JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Juniper Networks options imply 4.8% move in share price post-earnings QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Qualcomm options imply 4.6% move in share price post-earnings 01/30/23 Largest borrow rate increases among liquid names 01/23/23 Early notable gainers among liquid option names on January 23rd 08/31/22 Qualcomm sued by Arm for contract breach, infringement, Bloomberg says
Conference/Events	Church & Dwight to hold virtual analyst day » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 CHD Church & Dwight $79.75 / -1.665 (-2.05%) Virtual 2023 Analyst Day… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CHD Church & Dwight $79.75 / -1.665 (-2.05%) 09/06/22 Church & Dwight to acquire Hero Mighty Patch for $630M CHD Church & Dwight $79.75 / -1.665 (-2.05%) 01/17/23 Credit Suisse Church & Dwight upgraded to Outperform from Neutral at Credit Suisse 01/16/23 Morgan Stanley Church & Dwight upgraded to Overweight from Equal Weight at Morgan Stanley 01/13/23 JPMorgan Church & Dwight price target raised to $81 from $75 at JPMorgan 12/06/22 Deutsche Bank Church & Dwight price target raised to $90 from $85 at Deutsche Bank CHD Church & Dwight $79.75 / -1.665 (-2.05%) 02/02/23 Notable companies reporting before tomorrow's open 02/02/23 Notable companies reporting before tomorrow's open 10/28/22 Church & Dwight sees Q4 adjusted EPS 58c-62c, consensus 72c 10/28/22 Church & Dwight sees 2022 adjusted EPS $2.93-$2.97, consensus $2.97 CHD Church & Dwight $79.75 / -1.665 (-2.05%) 11/07/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/18/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 10/17/22 What You Missed On Wall Street On Monday 10/17/22 What You Missed On Wall Street This Morning 13:00 Today Church & Dwight - CHD 00:00 Today Church & Dwight CHD Church & Dwight $79.75 / -1.665 (-2.05%) 01/17/23 Early notable gainers among liquid option names on January 17th
Conference/Events	Piper Sandler health/pharma analysts to hold analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 TVTX Travere Therapeutics $22.54 / +0.48 (+2.18%) Healthcare/Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TVTX Travere Therapeutics $22.54 / +0.48 (+2.18%) 01/09/23 Travere Therapeutics provides 2023 anticipated milestones 10/13/22 Travere Therapeutics expects November 17 PDUFA target date for sparsentan 08/22/22 CSL, Travere announce EMA accepted review of CMA application for sparsentan 08/22/22 Travere, CSL announce EMA acceptance of CMA application for sparsentan TVTX Travere Therapeutics $22.54 / +0.48 (+2.18%) 01/30/23 Canaccord Travere Therapeutics price target raised to $40 from $33 at Canaccord 01/10/23 Piper Sandler Travere Therapeutics price target raised to $42 from $38 at Piper Sandler 12/20/22 Piper Sandler Piper recommends 'down market cap' biotech exposure for 2023 12/13/22 Stifel Travere Therapeutics initiated with a Hold at Stifel TVTX Travere Therapeutics $22.54 / +0.48 (+2.18%) 01/09/23 Travere Therapeutics sees Q4 net product sales $52M, consensus $57.15 10/27/22 Travere Therapeutics reports Q3 EPS (76c), consensus (86c) 08/04/22 Travere Therapeutics reports Q2 EPS ($1.05), consensus (88c) TVTX Travere Therapeutics $22.54 / +0.48 (+2.18%) 10/14/22 What You Missed On Wall Street On Friday 10/14/22 What You Missed On Wall Street This Morning 10/14/22 Fly Intel: Pre-market Movers 10/13/22 Fly Intel: After-Hours Movers 00:00 Today Healthcare/Pharmaceuticals 02/17/23 Proposed Extended PDUFA Date for Sparsentan
Conference/Events	JPMorgan networking equipment analyst to hold analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 JNPR Juniper $31.45 / +0.445 (+1.44%) , GLW Corning $36.31 / +1.025 (+2.90%) , QCOM Qualcomm $135.65 / -2.84 (-2.05%) Networking Equipment/IT… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNPR GLW QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Juniper CFO says aiming to expand 2023 operating margin by at least 100bps 12/12/22 Juniper selected as preferred technology partner for Deutsche Telekom's SD-X 12/07/22 Juniper CEO sells $604K in common stock 10/28/22 Juniper director Kriens sells 140,000 common shares GLW Corning $36.31 / +1.025 (+2.90%) 01/26/23 Corning Gorilla Glass Victus 2 used in Samsung Galaxy smartphones 01/18/23 PGT Innovations to partner with Corning on advanced window technologies 11/30/22 Corning unveils Corning Gorilla Glass Victus 2 09/15/22 Corning receives $103.8M in additional funding from BARDA QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Qualcomm expects weak handset market to persist through 1H23 02/02/23 Qualcomm sees Q2 QCT revenue $7.4B-$8B 02/02/23 Qualcomm CEO says long-term trends driving demand 'intact' 01/31/23 Mobile phone, PC shipments to fall another 4.4% in 2023, Gartner says JNPR GLW QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 02/01/23 Barclays Juniper price target raised to $40 from $34 at Barclays 02/01/23 Citi Juniper price target raised to $35 from $30 at Citi 01/17/23 Piper Sandler Juniper price target raised to $32 from $31 at Piper Sandler 12/20/22 JPMorgan JPMorgan ups Juniper target, adds to Analyst Focus List GLW Corning $36.31 / +1.025 (+2.90%) 02/02/23 Susquehanna Corning price target raised to $40 from $39 at Susquehanna 01/04/23 Credit Suisse Corning upgraded to Outperform from Neutral at Credit Suisse 12/20/22 JPMorgan Corning price target lowered to $40 from $44 at JPMorgan 12/13/22 Morgan Stanley Corning price target lowered to $35 from $36 at Morgan Stanley QCOM Qualcomm $135.65 / -2.84 (-2.05%) 01/23/23 Barclays Qualcomm upgraded to Overweight from Equal Weight at Barclays 01/18/23 Citi Citi opens 'negative catalyst watch' on Intel and Qualcomm 01/11/23 KeyBanc KeyBanc says iPhone survey shows supply partial recovery, some shortages remain 01/10/23 Piper Sandler Piper Sandler sees no strategic reason for Apple to insource Wi-Fi combo chip JNPR GLW QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Juniper raises quarterly dividend to 22c from 21c per share 01/31/23 Juniper sees Q1 EPS 37c-47c, consensus 40c 01/31/23 Juniper reports preliminary Q4 EPS 65c, consensus 65c 01/31/23 Notable companies reporting after market close GLW Corning $36.31 / +1.025 (+2.90%) 01/31/23 Corning sees Q1 core EPS 35c-42c, consensus 47c 01/31/23 Corning reports Q4 adjusted EPS 47c, consensus 44c 01/30/23 Notable companies reporting before tomorrow's open 01/30/23 Notable companies reporting before tomorrow's open QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Qualcomm sees Q2 adjusted EPS $2.05-$2.25, consensus $2.26 02/02/23 Qualcomm reports Q1 adjusted EPS $2.37, consensus $2.34 02/02/23 Notable companies reporting after market close 11/02/22 Qualcomm sees Q1 adjusted EPS adjusted EPS $2.25-$2.45, consensus $3.42 JNPR QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 08/27/22 Juniper Networks' AI strategy could push stock higher, Barron's says QCOM Qualcomm $135.65 / -2.84 (-2.05%) 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/30/23 U.S. considers cutting off Huawei fully from U.S. suppliers, Bloomberg says 01/11/23 TSMC receives 3nm chip orders from Broadcom, DigiTimes reports 01/09/23 Apple aims to replace Broadcom modem by 2025, Bloomberg says JNPR QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Fly Intel: After-Hours Movers 10/25/22 Fly Intel: After-Hours Movers 08/17/22 Here's what Wall Street experts are saying about Cisco ahead of earnings QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Fly Intel: After-Hours Movers 02/02/23 What Wall Street is saying about Apple ahead of earnings 02/02/23 Here's what Wall Street is saying about Qualcomm ahead of earnings 01/23/23 What You Missed On Wall Street On Monday 10:30 Today Networking Equipment/IT Hardware 13:30 Today Networking Equipment/IT Hardware 02/08/23 Networking Equipment/IT Hardware 02/15/23 Juniper 02/16/23 Juniper 03/08/23 Qualcomm Inc. JNPR GLW QCOM JNPR Juniper $31.45 / +0.445 (+1.44%) 01/31/23 Juniper Networks options imply 4.8% move in share price post-earnings GLW Corning $36.31 / +1.025 (+2.90%) 08/29/22 Corning put volume heavy and directionally bearish QCOM Qualcomm $135.65 / -2.84 (-2.05%) 02/02/23 Qualcomm options imply 4.6% move in share price post-earnings 01/30/23 Largest borrow rate increases among liquid names 01/23/23 Early notable gainers among liquid option names on January 23rd 08/31/22 Qualcomm sued by Arm for contract breach, infringement, Bloomberg says

Conference/Events	Contango Ore management to meet virtually with Roth MKM » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 CTGO Contango Ore $24.49 / + (+0.00%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events CTGO Contango Ore $24.49 / + (+0.00%) 10/31/22 Roth Capital Contango Ore initiated with a Buy at Roth Capital 00:00 Today Contango Ore
Conference/Events	Leslie's management to meet virtually with Loop Capital » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 LESL Leslie's $16.72 / +0.57 (+3.53%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events LESL Leslie's $16.72 / +0.57 (+3.53%) 09/29/22 Leslie's publishes annual ESG report 09/28/22 Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28 09/23/22 Leslie's to replace GCP Applied Technologies in S&P 600 at open on 9/28 LESL Leslie's $16.72 / +0.57 (+3.53%) 12/01/22 Stifel Leslie's downgraded to Hold from Buy at Stifel 11/28/22 Stifel Leslie's price target lowered to $17 from $20 at Stifel 11/15/22 Baird Leslie's downgraded to Neutral from Outperform at Baird 10/03/22 MKM Partners MKM Partners starts Leslie's at Neutral, sees higher costs impact profitability LESL Leslie's $16.72 / +0.57 (+3.53%) 02/02/23 Leslie's reports Q1 EPS (16c), consensus (12c) 11/30/22 Leslie's sees 2023 adjusted EPS 78c-86c, consensus 93c 11/30/22 Leslie's reports Q4 adjusted EPS 35c, consensus 31c 11/29/22 Notable companies reporting before tomorrow's open 09 Dec LESL Leslie's $16.72 / +0.57 (+3.53%) 02/02/23 Fly Intel: After-Hours Movers 11/30/22 What You Missed On Wall Street On Wednesday 11/30/22 What You Missed On Wall Street This Morning 11/30/22 Fly Intel: Pre-market Movers 00:00 Today Leslie's 03/16/23 Leslie's, Inc.
Conference/Events	Piper Sandler economist to hold an analyst/industry conference call » 04:55 02/03/23 02/03 04:55 02/03/23 04:55 Chief Economist Lazar and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	Provident Financial downgraded to Hold from Add at Peel Hunt » 04:54 02/03/23 02/03 04:54 02/03/23 04:54 FPLPF Provident Financial $1.98 / + (+0.00%) Peel Hunt analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FPLPF Provident Financial $1.98 / + (+0.00%) 10/20/22 Barclays Provident Financial price target lowered to 310 GBp from 370 GBp at Barclays 10/19/22 Keefe Bruyette Provident downgraded to Underperform from Market Perform at Keefe Bruyette
Downgrade	Merck KGaA downgraded to Sell from Buy at DZ Bank » 04:53 02/03/23 02/03 04:53 02/03/23 04:53 MKGAY Merck KGaA $38.36 / + (+0.00%) DZ Bank analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research MKGAY Merck KGaA $38.36 / + (+0.00%) 12/22/22 Mersana reports research collaboration, commercial license pact with Merck KGaA MKGAY Merck KGaA $38.36 / + (+0.00%) 02/02/23 Citi Merck KGaA downgraded to Neutral from Buy at Citi 01/06/23 Morgan Stanley Merck KGaA upgraded to Overweight from Equal Weight at Morgan Stanley 12/14/22 UBS Merck KGaA upgraded to Buy from Neutral at UBS 11/14/22 BofA Merck KGaA upgraded to Buy from Neutral at BofA

Events

Earnings calls, analyst events, roadshows and more

AVTR
Today at 08:00

Avantor - AVTR Conference Calls
TWST
Today at 08:00

Twist Bioscience - TWST Conference Calls
SNY
Today at 08:00

Sanofi - SNY Conference Calls
Today at 08:30

Employment Situation: Average Hourly Earnings Y/Y: January 2023 Government Event
Today at 08:30

Employment Situation--Unemployment Rate: January 2023 Government Event
Today at 08:30

Employment Situation: Average Workweek: January 2023 Government Event
Today at 08:30

Employment Situation: Private Payrolls M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Manufacturing Payrolls M/M: January 2023 Government Event
Today at 08:30

Employment Situation: Participation Rate: January 2023 Government Event
Today at 08:30

Employment Situation: Average Hourly Earnings M/M: January 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	VERA X VERA Vera Therapeutics Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LIFC Priced at: $7.00 14.286M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	ALGM X ALGM Allegro MicroSystems Block Trade Managers: Credit Suisse Priced at: $38.00 4.98M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPCR X GPCR Structure Therapeutics IPO Managers: Jefferies, SVB Securities, Guggenheim & BMO Capital Priced at: $15.00 10.74M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ROIV X ROIV Roivant Sciences Secondary Managers: Goldman Sachs, SVB Securities, Cowen & Cantor Fitzgerald Priced at: $7.50 26.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AVTX X AVTX Avalo Therapeutics Spot Secondary Managers: SVB Securities & RBC Capital Priced at: $3.98 3.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDBL X EDBL Edible Garden Spot Secondary Managers: Maxim & Joseph Gunnar Priced at: $6.30 1.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	WULF X WULF TeraWulf Spot Secondary Managers: JonesResearch $1.03
Thurs	ASST X ASST Asset Entities IPO Managers: Boustead $5.00 1.5M Shares SODR X SODR Sondors IPO Managers: DA Davidson & Lake Street $8.00 - 10.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDXH X MDXH MDxHealth Secondary Managers: Cowen & William Blair, BTIG, KBCS $6.75 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CLLS X CLLS Cellectis Spot Secondary Managers: Jefferies & Barclays $3.26 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TWO X TWO Two Harbors Spot Secondary Managers: Goldman Sachs, JPMorgan & Citi, JMP Securities $17.80-18.00 10M Shares
Fri	No deals

View All Syndicate Announcements »

Herborium Group shares a shareholders update letter part 2

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access